Thus, one would expect that (1) TR-rDNA stimulates the well-studied signaling pathway TLR9–MyD88–NF-kB, and (2) TR-rDNA oxidizes easily on the surface of the cancer cells and after oxidation, it can induce the DNA damage response (DDR) in the cell. The gene discussed is TLR9; the disease is cancer.